Gain Therapeutics

Bethesda, United States

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

$7.0M raised

Jul 2025

Post-IPO Equity

Biotechnology Health Care Pharmaceutical Therapeutics

Top Investors

Innosuisse 3B Future Health Fund Eurostars Horizon 2020 TiVentures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gain Therapeutics

How much funding has Gain Therapeutics raised?

Gain Therapeutics has raised $7.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.

Who are Gain Therapeutics's investors?

Gain Therapeutics's investors include Innosuisse, 3B Future Health Fund, Eurostars, Horizon 2020, TiVentures.

Where is Gain Therapeutics headquartered?

Gain Therapeutics is headquartered in Bethesda, United States.

What does Gain Therapeutics do?

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

What stage is Gain Therapeutics at?

Gain Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 16, 2025.

MLA

"Gain Therapeutics — Funding & Investors." VCBacked, July 16, 2025, https://www.vcbacked.co/company/gain-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Gain Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/gain-therapeutics

Wikipedia (cite web)

{{cite web |title=Gain Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/gain-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 16, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K